Adenocarcinoma: all 1,996 studies
Page 14 of 20. Open to participants first (369), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic NeoplasmsStatus unknownNCT03435770Not applicable
- OPPOSITE: Outcome Prediction of Systemic Treatment in Esophagogastric CarcinomaCompletedNCT03429816Not applicable
- Siewert Type II Esophageal Adenocarcinoma: Relationship Between Histology and SurvivalCompletedNCT03416101
- Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric AdenocarcinomaCompletedNCT03409848Phase 2
- A Multicentre Phase II Trial of Durvalumab Versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell AdenocarcinomasStatus unknownNCT03405454Phase 2
- Study of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric AdenocarcinomaStatus unknownNCT03400592Phase 2
- Study Title: Peri-operative Immuno-Chemotherapy in Operable Oesophageal and Gastric CancerActive, not recruitingNCT03399071Phase 2
- Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal AdenocarcinomaCompletedNCT03395847Early Phase 1
- Dose Escalation Using Fiducial Markers in Image Guided Volumetric Modulated Arc Therapy to the Focal Lesion Micro Boost of Localized Prostate CancerCompletedNCT03384199Phase 2
- Study of Apatinib as the Maintenance Therapy in Advanced Lung AdenocarcinomaStatus unknownNCT03376737Phase 2
- VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal CancerCompletedNCT03373188Phase 1
- Study of the Practice of Debiri in FranceStatus unknownNCT03369041
- TAS102 in Combination With NAL-IRI in Advanced GI CancersActive, not recruitingNCT03368963Phase 1/2
- Concurrent Neoadjuvant Chemoradiotherapy Plus Trastuzumab in the Treatment of Siewert II ，III of Human Epidermal Growth Factor Receptor-2(HER-2) Positive Gastroesophageal Junction Adenocarcinoma： A Randomized, Controlled Clinical StudyStatus unknownNCT03368131Phase 2
- Combination Nab-paclitaxel (N-P) and Nintedanib or N-P and Placebo in Relapsed NSCLC AdenocarcinomaWithdrawnNCT03361319Phase 1/2
- A Prospective Study of Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy for Siewert II ，III of Locally Advanced HER-2 Negative Adenocarcinoma at Gastroesophageal JunctionStatus unknownNCT03349866Phase 2
- A Pilot Study of IRE for Resectable Pancreatic CancerWithdrawnNCT03337997Not applicable
- Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive CytologyCompletedNCT03330028Phase 1
- Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate CancerTerminatedNCT03327662Phase 3
- CAR T Cell Immunotherapy for Pancreatic CancerTerminatedNCT03323944Phase 1
- Systematic Sampling of Lymph Nodes vs. Lymphadenectomy According to Intraoperative Frozen Pathology for Pulmonary Invasive Adenocarcinoma With Ground-glass OpacityStatus unknownNCT03322826Not applicable
- Assessment of Metabolic & Path Response w/ RCT & ImT Before Surgery in Locally Advanced Esoph and Gastro-esoph Jction CAWithdrawnNCT03307941Phase 1/2
- mDCF + Avelumab in Resectable Esophago-gastric Adenocarcinoma (EGA)Status unknownNCT03288350Phase 2
- Impact of an Endoscopic Treatment of the Line Z on the Gastronomic Recurrence and the Gastro- Esophageal Reflux Disease in the Care of the Adenocarcinoma of Barrett's OesophagusStatus unknownNCT03278327Not applicable
- To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal AdenocarcinomasTerminatedNCT03277209Phase 1
- Borderline Resectable or Resectable or Advanced Pancreatic AdenocarcinomaCompletedNCT03266757
- A Study of the Use of Irreversible Electroporation in Pancreatic Ductal CancerCompletedNCT03257150Not applicable
- Postoperative Pembrolizumab for the Patients Who Have Solid Predominant or Micropapillary Lung Adenocarcinoma With Pathologic Stage I and Primary Tumor Than 4 cmStatus unknownNCT03254004Phase 2
- Phase I Study of the Combination of Apatinib and POFStatus unknownNCT03244774Phase 1
- Very Low Carbohydrate Diet Effects to GPS, Serum Lactate and TNF Alpha on Colorectal CancerStatus unknownNCT03221920Not applicable
- PEN-866 in Patients With Advanced Solid MalignanciesStatus unknownNCT03221400Phase 1/2
- Microbiome Involvement With Barrett's Esophagus and Progression to Esophageal AdenocarcinomaStatus unknownNCT03216135
- Neoadjuvant Chemotherapy Response Assessment by Combined PET-MRI in Borderline and Locally Advanced Pancreatic Adenocarcinoma.Status unknownNCT03202199Not applicable
- Study of Crenolanib With Ramucirumab and Paclitaxel for Advanced Esophagogastric AdenocarcinomaCompletedNCT03193918Phase 1
- Effects of Wound Infiltration With Ketamine Versus Dexmedetomidine Added to Bupivacaine on CytokinesCompletedNCT03164590Phase 4
- Clinical Study of CAR-CLD18 T Cells in Patients With Advanced Gastric Adenocarcinoma and Pancreatic AdenocarcinomaStatus unknownNCT03159819Not applicable
- Exhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver TumorsStatus unknownNCT03149523
- Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing SurgeryWithdrawnNCT03147196Phase 2
- Comparing Total Laparoscopic Versus Open PancreaticoduodenectomyStatus unknownNCT03138213Not applicable
- QUILT-2.022 NANT-008 in Combination w/ 5-fluorouracil, Bevacizumab, Leucovorin & Oxaliplatin in Subjects With Pancreatic CancerWithdrawnNCT03127124Phase 1/2
- Study Comparing HAI Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLMStatus unknownNCT03125161Phase 3
- Apatinib Plus Irinotecan as Second-line Treatment in AGC or EGJAStatus unknownNCT03116555Phase 2
- Irreversible Electroporation (NanoKnife) for the Treatment of Pancreatic AdenocarcinomaCompletedNCT03105921Not applicable
- Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung AdenocarcinomaStatus unknownNCT03090815
- Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT03083613Phase 2
- A Study Evaluating MM-310 in Patients With Solid TumorsStatus unknownNCT03076372Phase 1
- Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic CancerActive, not recruitingNCT03073785Phase 2
- Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the LiverWithdrawnNCT03069950Phase 2
- The Microenvironment in Barrett's EsophagusCompletedNCT03060642
- Factors Associated With High Mortality of Gastric Adenocarcinoma in Thailand Versus JapanCompletedNCT03059732
- Metformin With Neoadjuvant Chemoradiation to Improve Pathologic Responses in Rectal CancerCompletedNCT03053544Phase 2
- Study of Vismodegib in Advanced Gastric Adenocarcinoma Patients With SMO OverexpressionCompletedNCT03052478Phase 2
- mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJAStatus unknownNCT03045770Not applicable
- Diagnostic Accuracy of Circulating Tumor Cells (CTCs) and Onco-exosome Quantification in the Diagnosis of Pancreatic Cancer - PANC-CTCCompletedNCT03032913
- Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJAStatus unknownNCT03030937Phase 2
- Detection of CSF Next Generation Sequencing in the Application of Brain Metastases From Lung Adenocarcinoma or Meningeal MetastasisStatus unknownNCT03029065
- Trastuzumab Based Therapy in HER2 Positive AGCCompletedNCT03024450
- Wide Area Transepithelial Sample Esophageal Biopsy Combined With Computer Assisted 3-Dimensional Tissue Analysis (WATS3D) For the Detection of High Grade Esophageal Dysplasia and AdenocarcinomaCompletedNCT03015389
- PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant ChemotherapyCompletedNCT03013010Phase 3
- Translational Research on Locally Advanced Pancreatic AdenocarcinomaStatus unknownNCT03009253Not applicable
- MLN8237 for a Subject With Adenocarcinoma of the ProstateNo longer availableNCT03005262
- Surveillance of Patients With Adenocarcinoma of the Gastroesophageal Junction or EsophagusTerminatedNCT02991547
- Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma (ECTOP-1002)CompletedNCT02980991Phase 2
- Poziotinib in Stage IV Lung Adenocarcinoma With HER2 Mutation (KASTT001)CompletedNCT02979821Phase 2
- Management of Symptomatic Advanced Pancreatic AdenocarcinomaActive, not recruitingNCT02979483Not applicable
- The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal AdenocarcinomaStatus unknownNCT02978547Phase 2
- Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic AdenocarcinomaCompletedNCT02977702
- Stereotactic Hypofractionated Accelerated Radiotherapy Post-ProstatectomyStatus unknownNCT02976402Phase 1
- Phenotyping of Small Bowel AdenocarcinomaCompletedNCT02976090
- EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNACompletedNCT02975752
- Changes in Biomarkers From Blood Over Time in Patients With Pancreatic AdenocarcinomaCompletedNCT02974764
- Exercise Prior to OesophagectomyStatus unknownNCT02962219Not applicable
- Decitabine and Gemcitabine for Pancreatic Cancer and SarcomaCompletedNCT02959164Phase 1
- A Safety Study of SGN-2FF for Patients With Advanced Solid TumorsTerminatedNCT02952989Phase 1
- Application of Detecting Circulating Tumor Cells in the Accurate Treatment of Early Stage Lung AdenocarcinomaStatus unknownNCT02951897Not applicable
- Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled TrialStatus unknownNCT02951637Phase 2
- A Study of Laparoscopic Right Hemicolectomy Using the Caudal-to-cranial ApproachStatus unknownNCT02949440Not applicable
- A+C in Metastatic Lung Adenocarcinoma CancerStatus unknownNCT02946359Phase 2
- Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the ProstateStatus unknownNCT02944201Phase 2
- A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and StomachWithdrawnNCT02943603Phase 2
- In the Era of the HPV Vaccine, What Are The Current HPV Subtypes Contributing to High Grade Cervical Dysplasia, Adenocarcinoma in Situ, and Early Cervical Cancer?Status unknownNCT02937155
- Capecitabine and Lenvatinib With External Radiation in Rectal AdenocarcinomaCompletedNCT02935309Phase 1
- Evaluation of the Resection of Adenoma and Colic Adenocarcinoma by EMR Piecemeal or EMR/ESD Hybrid TechniqueStatus unknownNCT02935049
- Clinical Study of YYJD Decoction Combined With Gefitinib in Advanced Pulmonary AdenocarcinomaStatus unknownNCT02929693Phase 3
- Study of NAC of GA Therapy for Patients With BRPCStatus unknownNCT02926183Phase 2
- Neo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced Rectal CancerStatus unknownNCT02919878Phase 2
- The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCCStatus unknownNCT02915432Phase 1/2
- PEGPH20 Plus Gemcitabine With Radiotherapy in Patients With Localized, Unresectable Pancreatic CancerTerminatedNCT02910882Phase 2
- A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)CompletedNCT02900664Phase 1
- Chemoresistance and Involvement of the NOTCH Pathway in Patients With Lung AdenocarcinomaStatus unknownNCT02898857
- Diffusion MRI for Pancreatic AdenocarcinomaCompletedNCT02896946Not applicable
- Stereotactic Body Radiation Therapy (SBRT) in Newly Diagnosed Advanced Staged Lung Adenocarcinoma (Sindas)TerminatedNCT02893332Phase 3
- Retrospective Analysis of the Expression of the Neurotensin Receptor by Metastatic Lung AdenocarcinomasWithdrawnNCT02891733
- Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary AdenocarcinomaCompletedNCT02889692Phase 3
- Durvalumab Plus "Booster" RT for Metastatic Adenocarcinoma Pancreas Cancer Post Chemotherapy (GCC 1598)WithdrawnNCT02885727Phase 2
- Evaluation of Sodium Fluoride PET in the Identification of Bone Metastases in Patients Having Undergone a Choline PET for Occult Recurrence of Prostatic AdenocarcinomaStatus unknownNCT02876991Not applicable
- Phase II Study of Afatinib as Third- or Further-line Treatment for Patients With Stage IV Bronchial Adenocarcinoma, Harboring Wild-type EGFR, Expressing the Neurotensin - Neurotensin Receptor ComplexWithdrawnNCT02876081Phase 2
- Study on Hyperthermic Intraperitoneal Chemotherapy After Resection of PancreascarcinomaStatus unknownNCT02863471Phase 1/2
- Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN)WithdrawnNCT02856867Phase 2
- HIPEC as Neoadjuvant Treatment for Resectable Pancreatic AdenocarcinomaWithdrawnNCT02850874Phase 2